NO20016341D0 - Inhibitors for the integrin <alfa> v <beta> 6 - Google Patents

Inhibitors for the integrin <alfa> v <beta> 6

Info

Publication number: NO20016341D0
Authority: NO; Norway
Prior art keywords: alfa; integrin; inhibitors; beta
Prior art date: 1999-06-26

Application number

NO20016341A

Other languages

Norwegian (no)

Other versions

NO20016341L (en

Inventor

Alfred Jonczyk

Beate Diefenbach

Ulrich Groth

Gunther Zischinsky

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-26

Filing date

2001-12-21

Publication date

2001-12-21

2001-12-21 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2001-12-21 Publication of NO20016341D0 publication Critical patent/NO20016341D0/en

2002-02-25 Publication of NO20016341L publication Critical patent/NO20016341L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Oncology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

NO20016341A 1999-06-26 2001-12-21 Inhibitors for the integrin <alfa> v <beta> 6 NO20016341L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19929410A DE19929410A1 (en)	1999-06-26	1999-06-26	New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
PCT/EP2000/005404 WO2001000660A1 (en)	1999-06-26	2000-06-13	INHIBITORS OF THE INTEGRIN αvβ¿6?

Publications (2)

Publication Number	Publication Date
NO20016341D0 true NO20016341D0 (en)	2001-12-21
NO20016341L NO20016341L (en)	2002-02-25

Family

ID=7912712

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20016341A NO20016341L (en)	1999-06-26	2001-12-21	Inhibitors for the integrin <alfa> v <beta> 6

Country Status (17)

Country	Link
EP (1)	EP1189930A1 (en)
JP (1)	JP2003503422A (en)
KR (1)	KR20020015704A (en)
CN (1)	CN1358195A (en)
AR (1)	AR024472A1 (en)
AU (1)	AU771099B2 (en)
BR (1)	BR0011954A (en)
CA (1)	CA2377224A1 (en)
CZ (1)	CZ20014484A3 (en)
DE (1)	DE19929410A1 (en)
HU (1)	HUP0201729A3 (en)
MX (1)	MXPA01013247A (en)
NO (1)	NO20016341L (en)
PL (1)	PL352374A1 (en)
SK (1)	SK18722001A3 (en)
WO (1)	WO2001000660A1 (en)
ZA (1)	ZA200200673B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6972296B2 (en)	1999-05-07	2005-12-06	Encysive Pharmaceuticals Inc.	Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
PL377560A1 (en) *	2003-02-06	2006-02-06	Merck Patent Gmbh	Peptidic sulfonamides
GB0520068D0 (en)	2005-10-03	2005-11-09	Cancer Res Technology	av peptide ligand
TW200815474A (en)	2006-08-03	2008-04-01	Astrazeneca Ab	Antibodies alphaVbeta6 and uses thereof
SI3535397T1 (en) *	2016-11-01	2022-04-29	Arrowhead Pharmaceuticals, Inc.	Alpha-v beta-6 integrin ligands and uses thereof
CN111526880A (en)	2017-11-01	2020-08-11	箭头药业股份有限公司	Integrin ligands and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992020708A1 (en) *	1991-05-14	1992-11-26	Board Of Regents For The University Of Oklahoma	Peptide inhibitors of inflammation
CA2297736A1 (en) *	1997-08-08	1999-02-18	The Regents Of The University Of California	Treatment of acute lung injury and fibrosis with antagonists of .alpha.v.beta.6
JP2002533064A (en) *	1998-12-19	2002-10-08	メルクパテントゲゼルシャフトミットベシュレンクテルハフトング	Integrin αvβ6 inhibitor

1999
- 1999-06-26 DE DE19929410A patent/DE19929410A1/en not_active Withdrawn
2000
- 2000-06-13 KR KR1020017016580A patent/KR20020015704A/en not_active Application Discontinuation
- 2000-06-13 CA CA002377224A patent/CA2377224A1/en not_active Abandoned
- 2000-06-13 MX MXPA01013247A patent/MXPA01013247A/en unknown
- 2000-06-13 EP EP00949177A patent/EP1189930A1/en not_active Withdrawn
- 2000-06-13 JP JP2001507066A patent/JP2003503422A/en active Pending
- 2000-06-13 PL PL00352374A patent/PL352374A1/en unknown
- 2000-06-13 SK SK1872-2001A patent/SK18722001A3/en unknown
- 2000-06-13 CZ CZ20014484A patent/CZ20014484A3/en unknown
- 2000-06-13 AU AU62630/00A patent/AU771099B2/en not_active Ceased
- 2000-06-13 BR BR0011954-7A patent/BR0011954A/en not_active IP Right Cessation
- 2000-06-13 HU HU0201729A patent/HUP0201729A3/en unknown
- 2000-06-13 CN CN00809493A patent/CN1358195A/en active Pending
- 2000-06-13 WO PCT/EP2000/005404 patent/WO2001000660A1/en not_active Application Discontinuation
- 2000-06-23 AR ARP000103177A patent/AR024472A1/en not_active Application Discontinuation
2001
- 2001-12-21 NO NO20016341A patent/NO20016341L/en not_active Application Discontinuation
2002
- 2002-01-24 ZA ZA200200673A patent/ZA200200673B/en unknown

Also Published As

Publication number	Publication date
CN1358195A (en)	2002-07-10
JP2003503422A (en)	2003-01-28
HUP0201729A2 (en)	2002-08-28
MXPA01013247A (en)	2002-07-02
DE19929410A1 (en)	2000-12-28
AR024472A1 (en)	2002-10-02
NO20016341L (en)	2002-02-25
AU771099B2 (en)	2004-03-11
SK18722001A3 (en)	2002-05-09
AU6263000A (en)	2001-01-31
BR0011954A (en)	2002-05-07
EP1189930A1 (en)	2002-03-27
CA2377224A1 (en)	2001-01-04
ZA200200673B (en)	2003-04-24
CZ20014484A3 (en)	2002-04-17
WO2001000660A1 (en)	2001-01-04
PL352374A1 (en)	2003-08-25
KR20020015704A (en)	2002-02-28
HUP0201729A3 (en)	2005-01-28

Publication	Publication Date	Title
NO20006268D0 (en)	2000-12-11	<Beta> karbolinforbindelser
DE69836425D1 (en)	2006-12-28	container
DE60044873D1 (en)	2010-10-07	ORIENTED BIOPOLYMERMEMBRANES
DE69911627D1 (en)	2003-10-30	ISSUE CONTAINER
DE59911165D1 (en)	2005-01-05	Lyophilisier container
DK1063178T3 (en)	2004-12-06	Container connection arrangement
FI990170A0 (en)	1999-01-29	The metering
DE69907015D1 (en)	2003-05-22	ISSUE CONTAINER
ATA24499A (en)	2002-11-15	CONTAINER
DE60020654D1 (en)	2005-07-14	container
ID28483A (en)	2001-05-31	2- (3,5-BIS-TRIFLUOROMETYL-PHENIL) -METIL-N- (6-MORFOLIN-4-IL-4-0-TOLYL-PYRIDIN-3-IL) -ISOBUTIRAMIDA
NO20013013L (en)	2001-06-18	<Alpha> v <beta> 6-integrin
FI990553A (en)	2000-09-13	The measuring arrangement
NO20014010L (en)	2001-10-18	<Beta> -alaninderivater
IS6191A (en)	2001-12-05	container
DE69928440D1 (en)	2005-12-22	ISSUE CONTAINER
NO20022852L (en)	2002-08-15	Containers
NO20016341D0 (en)	2001-12-21	Inhibitors for the integrin <alfa> v <beta> 6
FI980908A0 (en)	1998-04-24	The reel
DE60023871D1 (en)	2005-12-15	BIN
EP1192168A4 (en)	2003-04-16	GALECTINE 11
NO20020886D0 (en)	2002-02-22	Novel integrin <alfa> v <beta> 3 inhibitors
EP1082152A4 (en)	2002-02-06	PRE-FILLER CONTAINER
NO20030925D0 (en)	2003-02-27	Gem-substituted alpha V beta 3 integrin antagonists
ATA36698A (en)	2005-04-15	CONTAINER

Legal Events

Date	Code	Title	Description
2005-04-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application